Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-026624

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Sep 3, 2015
Accepted (ET)
Sep 4, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 3, 2015M4,115$34.56A4,355D
Common StockF3Sep 3, 2015S4,115$154.7869D240D
Common StockF2Sep 3, 2015M5,547$30.75A5,787D
Common StockF4Sep 3, 2015S700$150.4314D5,087D
Common StockF5Sep 3, 2015S1,687$151.4838D3,400D
Common StockF6Sep 3, 2015S756$152.6638D2,644D
Common StockF7Sep 3, 2015S1,112$153.9451D1,532D
Common StockF8Sep 3, 2015S1,087$154.91D445D
Common StockF9Sep 3, 2015S205$155.7463D240D
Common Stockholding———166IBy Spouse
Common Stockholding———625,031IBy Trusts

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$34.56Sep 3, 2015M4,115DDec 30, 2005Dec 30, 2015Common Stock4,11539,733D
Stock Options$30.75Sep 3, 2015M5,547DDec 26, 2009Dec 31, 2017Common Stock5,547388,255D

Explanation of responses